These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15817920)

  • 1. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S; Claus M; Paschke R
    Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation.
    Neumann S; Krause G; Chey S; Paschke R
    Mol Endocrinol; 2001 Aug; 15(8):1294-305. PubMed ID: 11463854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
    Kosugi S; Shenker A; Mori T
    FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
    Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
    Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
    Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.
    Kleinau G; Jaeschke H; Mueller S; Raaka BM; Neumann S; Paschke R; Krause G
    FASEB J; 2008 Aug; 22(8):2798-808. PubMed ID: 18381815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
    Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
    Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
    Jaeschke H; Schaarschmidt J; Günther R; Mueller S
    Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
    Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
    Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling.
    Claus M; Jaeschke H; Kleinau G; Neumann S; Krause G; Paschke R
    Endocrinology; 2005 Dec; 146(12):5197-203. PubMed ID: 16150909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity.
    Ho SC; Goh SS; Su Q; Khoo DH
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):158-68. PubMed ID: 16364538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.
    Schaarschmidt J; Huth S; Meier R; Paschke R; Jaeschke H
    PLoS One; 2014; 9(10):e111570. PubMed ID: 25340405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene.
    Costagliola S; Sunthorntepvarakul T; Migeotte I; Van Sande J; Kajava AM; Refetoff S; Vassart G
    Thyroid; 1999 Oct; 9(10):995-1000. PubMed ID: 10560953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
    Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
    Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
    Zhang ML; Sugawa H; Kosugi S; Mori T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.